Building a Differentiated Obesity Biotech

from Running Through Walls · host Venrock, a venture capital firm

Metsera CEO Whit Bernard joins Venrock's Nimish Shah to discuss how the company's ultra-long acting GLP-1 program helped position it as a strategic standout in the obesity market. The conversation covers the bidding war between major pharma players, lessons in first-principles company building, and why the next decade of biotech could reward high-volume, accessible innovation.

Episode metadata supplied by the publisher feed · Published Jun 23, 2026

Embed this episode

Attribution link and audio player

Ready to play

Building a Differentiated Obesity Biotech

0:00 24:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world.

Frequently Asked Questions

How long is this episode of Running Through Walls?

This episode is 24 minutes long.

When was this Running Through Walls episode published?

This episode was published on June 23, 2026.

Can I download this Running Through Walls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!